Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression
ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma
Aragen launches India’s first women-led chemistry synthesis laboratory
Vaccine strategy induces broadly neutralising HIV antibodies
Potential biomarker for targeted psoriasis therapy discovered
Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin
Sobi boosts gout battle with Arthrosi Therapeutics acquisition
Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints
First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
Breast cancer vaccine endpoints met with 74% immune response